Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have proposed that reduced activity of inosine-5'-monophosphate dehydrogenase (
IMPD
; IMP:NAD oxidoreductase, EC 1.2.1.14), the rate-limiting enzyme for guanine nucleotide biosynthesis, in response to wild-type
p53
expression, is essential for
p53
-dependent growth suppression. A gene transfer strategy was used to demonstrate that under physiological conditions constitutive
IMPD
expression prevents
p53
-dependent growth suppression. In these studies, expression of bax and waf1, genes implicated in
p53
-dependent growth suppression in response to DNA damage, remains elevated in response to
p53
. These findings indicate that under physiological conditions
IMPD
is a rate-determining factor for
p53
-dependent growth regulation. In addition, they suggest that the impd gene may be epistatic to bax and waf1 in growth suppression. Because of the role of
IMPD
in the production and balance of GTP and ATP, essential nucleotides for signal transduction, these results suggest that
p53
controls cell division signals by regulating purine ribonucleotide metabolism.
...
PMID:Inosine-5'-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation. 943 88
Recently, we demonstrated that downregulation of inosine-5'-monophosphate dehydrogenase (
IMPD
; IMP:NAD oxidoreductase, EC 1.2.1.14), the rate-limiting enzyme for guanine nucleotide biosynthesis, is required for
p53
-dependent growth suppression. These studies were performed with cell lines derived from immortal, nontumorigenic fibroblasts that express wild-type
p53
conditionally by virtue of a metal-responsive promoter. Here, the
p53
-dependent properties of the original "p53-inducible" fibroblasts are presented in detail and compared to related properties of epithelial cells that also express wild-type
p53
conditionally, but by virtue of a temperature-responsive promoter. Both types of
p53
-inducible cells were designed to approximate normal physiologic relationships between the host cell and the regulated
p53 protein
. Together, they were used to investigate expression relationships between
IMPD
and other
p53
-responsive genes proposed as mediators of
p53
-dependent growth suppression. In both types of cells,
IMPD
activity, protein, and mRNA were consistently coordinately reduced in response to
p53
expression. In contrast, mRNAs for waf1, bax, and mdm2 showed disparate patterns of expression, being induced in one conditional cell type, but not the other. This distinction in regulation pattern suggests that under normal growth conditions, unlike
IMPD
downregulation, bax and waf1 induction is not a rate-determining event for
p53
-dependent growth suppression.
...
PMID:Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions. 976 33